Versago Vascular Access raises $1.65 mln seed
Versago Vascular Access Inc, a spinoff of Primo Medical Group, raised $1.65 million in seed funding from Primo’s network of individual and institutional investors. Based in West Bridgewater, Massachusetts, Versago is the developer of a "reverse needle" subcutaneous access port.
24 February 2016•3 mins read
